Top Vaccines companies in United States by Total Non-Current Liabilities
United States
# |
Name |
Total Non-Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 89.42 B
|
Dec. 31, 2023 | USD 26.52 | -1.45% |
|
United States |
|
| 2 |
USD 43.41 B
|
Dec. 31, 2023 | USD 58.95 | -0.32% |
|
United States |
|
| 3 |
USD 43.35 B
|
Dec. 31, 2023 | USD 98.82 | -0.13% |
|
United States |
|
| 4 |
USD 37.87 B
|
Dec. 31, 2023 | USD 597.75 | -1.48% |
|
United States |
|
| 5 |
USD 28.10 B
|
Dec. 31, 2023 | USD 97.20 | 0.26% |
|
United States |
|
| 6 |
USD 20.55 B
|
Dec. 31, 2023 | USD 127.93 | -0.68% |
|
United States |
|
| 7 |
USD 8.61 B
|
Dec. 31, 2023 | USD 143.93 | -1.57% |
|
United States |
|
| 8 |
USD 7.41 B
|
Dec. 31, 2023 | USD 170.90 | -1.05% |
|
United States |
|
| 9 |
USD 5.61 B
|
Dec. 31, 2023 | USD 249.80 | -0.69% |
|
United States |
|
| 10 |
USD 3.68 B
|
Dec. 31, 2023 | USD 672.98 | -1.48% |
|
United States |
|
| 11 |
USD 3.48 B
|
Dec. 30, 2023 | USD 164.76 | -0.49% |
|
United States |
|
| 12 |
USD 3.08 B
|
Dec. 31, 2023 | USD 271.31 | -2.11% |
|
United States |
|
| 13 |
USD 2.81 B
|
Dec. 31, 2023 | USD 56.05 | 0.04% |
|
United States |
|
| 14 |
USD 2.16 B
|
Dec. 31, 2023 | USD 31.90 | -4.26% |
|
United States |
|
| 15 |
USD 1.56 B
|
Dec. 31, 2023 | USD 39.42 | -3.95% |
|
United States |
|
| 16 |
USD 1.44 B
|
Dec. 31, 2023 | USD 76.58 | 0.38% |
|
United States |
|
| 17 |
USD 1.42 B
|
Dec. 31, 2023 | USD 46.98 | -5.93% |
|
United States |
|
| 18 |
USD 1.25 B
|
May 31, 2024 | USD 11.46 | -0.17% |
|
United States |
|
| 19 |
USD 1.11 B
|
Dec. 31, 2023 | USD 49.46 | -1.02% |
|
United States |
|
| 20 |
USD 1.03 B
|
Dec. 31, 2023 | USD 3.45 | -0.58% |
|
United States |
|
| 21 |
USD 937.13 M
|
Dec. 31, 2023 | USD 8.69 | -3.55% |
|
United States |
|
| 22 |
USD 845.57 M
|
Sept. 30, 2024 | USD 19.88 | -1.73% |
|
United States |
|
| 23 |
USD 822.50 M
|
Dec. 31, 2023 | USD 7.90 | 0.38% |
|
United States |
|
| 24 |
USD 617.24 M
|
Dec. 31, 2023 | USD 5.79 | -3.02% |
|
United States |
|
| 25 |
USD 522.60 M
|
Dec. 31, 2023 | USD 11.25 | 1.26% |
|
United States |
|
| 26 |
USD 521.39 M
|
June 30, 2024 | USD 21.81 | -0.77% |
|
United States |
|
| 27 |
USD 480.36 M
|
Aug. 31, 2023 | USD 12.01 | -2.36% |
|
United States |
|
| 28 |
USD 449.00 M
|
Dec. 31, 2023 | USD 12.90 | -3.59% |
|
United States |
|
| 29 |
USD 447.82 M
|
Dec. 31, 2023 | USD 5.99 | -5.52% |
|
United States |
|
| 30 |
USD 423.11 M
|
Dec. 31, 2023 | USD 7.54 | -2.46% |
|
United States |
|
| 31 |
USD 422.43 M
|
Dec. 31, 2023 | USD 1.52 | 0.66% |
|
United States |
|
| 32 |
USD 387.50 M
|
Dec. 31, 2023 | USD 17.61 | -1.57% |
|
United States |
|
| 33 |
USD 377.80 M
|
Dec. 31, 2023 | USD 351.17 | -0.32% |
|
United States |
|
| 34 |
USD 349.94 M
|
Dec. 31, 2023 | USD 8.62 | -2.49% |
|
United States |
|
| 35 |
USD 346.62 M
|
Dec. 31, 2023 | USD 29.01 | -4.54% |
|
United States |
|
| 36 |
USD 326.84 M
|
Dec. 31, 2023 | USD 17.93 | 2.93% |
|
United States |
|
| 37 |
USD 312.83 M
|
Dec. 31, 2023 | USD 13.05 | 0.31% |
|
United States |
|
| 38 |
USD 309.72 M
|
Dec. 31, 2023 | USD 1.66 | -3.49% |
|
United States |
|
| 39 |
USD 264.84 M
|
Dec. 31, 2023 | USD 7.75 | -1.40% |
|
United States |
|
| 40 |
USD 258.40 M
|
Dec. 31, 2023 | USD 106.46 | -2.20% |
|
United States |
|
| 41 |
USD 206.40 M
|
Dec. 31, 2023 | USD 3.80 | 7.34% |
|
United States |
|
| 42 |
USD 198.85 M
|
Dec. 31, 2023 | USD 18.28 | -1.19% |
|
United States |
|
| 43 |
USD 190.30 M
|
Sept. 30, 2024 | USD 5.11 | -0.58% |
|
United States |
|
| 44 |
USD 177.70 M
|
Dec. 31, 2023 | USD 1.51 | 0.67% |
|
United States |
|
| 45 |
USD 176.79 M
|
Dec. 31, 2023 | USD 1.70 | -1.73% |
|
United States |
|
| 46 |
USD 153.42 M
|
Dec. 31, 2023 | USD 10.40 | 0.87% |
|
United States |
|
| 47 |
USD 151.01 M
|
Sept. 30, 2024 | USD 7.50 | -1.32% |
|
United States |
|
| 48 |
USD 144.17 M
|
Dec. 31, 2023 | USD 16.15 | 0.31% |
|
United States |
|
| 49 |
USD 122.51 M
|
Dec. 31, 2023 | USD 8.88 | 4.59% |
|
United States |
|
| 50 |
USD 115.36 M
|
Dec. 31, 2023 | USD 31.70 | -4.98% |
|
United States |
Frequently Asked Questions
-
Which Vaccines company in United States has the highest Total Non-Current Liabilities ?
The Vaccines company in United States with the highest Total Non-Current Liabilities is Pfizer Inc. (NYSE: PFE) at USD 89.42 B.
-
Which Vaccines company in United States has the lowest Total Non-Current Liabilities ?
The Vaccines company in United States with the lowest Total Non-Current Liabilities is Protagonist Therapeutics, Inc. (NasdaqGM: PTGX) at USD 0.00.
-
What are the top 10 Vaccines companies in United States by Total Non-Current Liabilities ?
The top 10 Vaccines companies in United States by Total Non-Current Liabilities are Pfizer Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Thermo Fisher Scientific Inc., Gilead Sciences, Inc., Abbott Laboratories, Biogen Inc., Zoetis Inc., Laboratory Corporation of America Holdings and Regeneron Pharmaceuticals, Inc..
-
What are the bottom 10 Vaccines companies in United States by Total Non-Current Liabilities ?
The bottom 10 Vaccines companies in United States by Total Non-Current Liabilities are Protagonist Therapeutics, Inc., ARS Pharmaceuticals, Inc., Palisade Bio, Inc., Tourmaline Bio, Inc., Sera Prognostics, Inc., Dianthus Therapeutics, Inc., Gain Therapeutics, Inc., IDEAYA Biosciences, Inc., Terns Pharmaceuticals, Inc. and VYNE Therapeutics Inc..
